Direxion Daily S&P Biotech Bull 3x Shares Rating $108.26 +2.26 (+2.13%) (As of 02:05 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.77Holdings in LABU have an aggregate rating of Moderate Buy based on 655 analyst ratings issued in the past year covering 40 companies (44.9% of the portfolio).LABU Aggregate Price Target$108.26High Prediction$108.26Average Prediction$108.26Low Prediction$108.26Holdings in LABU have an aggregate price target of $108.26 and a range of $108.26 to $108.26 covering 40 companies (44.9% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.08%INCYIncyte$70.02-1.4%3.9108 of 5 stars2.38$77.16 10.2%21Analyst Forecast1.94%UTHRUnited Therapeutics$369.24+1.3%4.5228 of 5 stars2.73$370.86 0.4%15Analyst RevisionPositive News1.87%GILDGilead Sciences$89.56+1.0%4.6461 of 5 stars2.65$94.45 5.5%26Analyst UpgradePositive News1.75%NTRANatera$169.63+1.0%2.8143 of 5 stars3.00$140.59 -17.1%17Analyst Forecast1.70%NBIXNeurocrine Biosciences$125.70+2.0%4.9552 of 5 stars2.83$163.91 30.4%24Positive News1.66%ALNYAlnylam Pharmaceuticals$249.85+0.4%4.4125 of 5 stars2.71$298.09 19.3%24Analyst Forecast1.65%VRTXVertex Pharmaceuticals$450.71-0.1%4.0563 of 5 stars2.53$499.12 10.7%30Analyst DowngradeNews CoveragePositive News1.54%INSMInsmed$72.88+0.3%4.0926 of 5 stars3.00$83.07 14.0%16Positive News1.50%SRPTSarepta Therapeutics$111.03+0.2%4.914 of 5 stars3.00$181.33 63.3%22Analyst Downgrade1.49%VKTXViking Therapeutics$53.60+4.0%4.7807 of 5 stars3.09$109.80 104.9%11Analyst Forecast1.47%AMGNAmgen$290.14+0.8%4.9132 of 5 stars2.46$333.57 15.0%26Ex-DividendShort Interest ↓Positive News1.46%MDGLMadrigal Pharmaceuticals$327.55+3.3%3.784 of 5 stars2.69$347.33 6.0%13Analyst Forecast1.44%ABBVAbbVie$172.00+2.5%4.9638 of 5 stars2.90$203.37 18.2%21Analyst ForecastPositive News1.41%BIIBBiogen$157.89+1.2%4.8648 of 5 stars2.54$257.20 62.9%28Analyst Downgrade1.28%BMRNBioMarin Pharmaceutical$63.27+1.1%4.9884 of 5 stars2.74$94.20 48.9%23Analyst Revision1.25%EXASExact Sciences$53.53+1.6%4.8873 of 5 stars2.95$74.47 39.1%19Analyst ForecastPositive News1.17%REGNRegeneron Pharmaceuticals$752.85+1.3%4.8024 of 5 stars2.78$1,099.55 46.1%23Positive News1.16%CYTKCytokinetics$48.88-2.0%4.0477 of 5 stars2.75$83.93 71.7%16Analyst ForecastInsider TradeOptions VolumeNews Coverage1.09%BPMCBlueprint Medicines$97.85+3.2%2.7179 of 5 stars2.71$122.11 24.8%21Analyst ForecastAnalyst Revision1.07%HALOHalozyme Therapeutics$45.48-0.6%4.9797 of 5 stars2.60$61.11 34.4%10Analyst Forecast1.05%CRSPCRISPR Therapeutics$46.54-1.5%1.7975 of 5 stars2.37$74.94 61.0%191.04%MRNAModerna$37.77+2.2%4.5749 of 5 stars2.18$84.00 122.4%22Analyst UpgradeAnalyst Revision1.02%TGTXTG Therapeutics$34.96+12.2%4.2078 of 5 stars2.83$37.67 7.7%6Positive News0.96%RVMDRevolution Medicines$57.40+0.6%2.7998 of 5 stars3.08$61.00 6.3%120.90%RNAAvidity Biosciences$43.62-0.1%2.4064 of 5 stars3.00$63.22 44.9%9Insider TradeAnalyst Revision0.83%KRYSKrystal Biotech$182.90+2.7%4.7675 of 5 stars3.00$202.29 10.6%8Positive News0.82%ADMAADMA Biologics$21.48+0.5%3.3244 of 5 stars3.25$21.25 -1.1%40.77%EXELExelixis$34.86+0.6%4.7895 of 5 stars2.65$31.44 -9.8%20Insider Trade0.74%ROIVRoivant Sciences$11.93+3.8%3.1207 of 5 stars2.88$17.93 50.3%80.73%IONSIonis Pharmaceuticals$34.53-2.5%4.2328 of 5 stars2.68$60.65 75.6%190.72%ALKSAlkermes$27.76-0.5%4.7943 of 5 stars2.58$35.42 27.6%12Positive News0.67%BHVNBiohaven$46.46-0.8%3.9283 of 5 stars3.07$63.42 36.5%140.62%PCVXVaxcyte$90.97+5.8%3.3048 of 5 stars3.00$147.50 62.1%70.61%TWSTTwist Bioscience$42.12+2.5%4.15 of 5 stars2.67$51.78 22.9%9Analyst ForecastAnalyst RevisionNews Coverage0.61%IOVAIovance Biotherapeutics$8.23+1.1%4.0592 of 5 stars2.89$22.33 171.4%9Options Volume0.58%APLSApellis Pharmaceuticals$27.57+0.3%4.5293 of 5 stars2.75$49.94 81.2%20Analyst Forecast0.58%BBIOBridgeBio Pharma$23.52+2.1%4.5829 of 5 stars2.87$47.57 102.3%15Insider TradeAnalyst Revision0.55%CRNXCrinetics Pharmaceuticals$57.72+2.9%2.8397 of 5 stars2.91$70.18 21.6%11Analyst Revision0.55%GERNGeron$4.03+1.0%3.5335 of 5 stars3.00$7.05 74.9%110.54%ACLXArcellx$88.01+0.9%2.9367 of 5 stars3.07$103.08 17.1%14Short Interest ↓ This page (NYSEARCA:LABU) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts